178 related articles for article (PubMed ID: 34486497)
1. Transcription factor KLF2 enhances the sensitivity of breast cancer cells to cisplatin by suppressing kinase WEE1.
Li R; Chen J; Gao X; Jiang G
Cancer Biol Ther; 2021 Sep; 22(7-9):465-477. PubMed ID: 34486497
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis.
Wang F; Zhu Y; Huang Y; McAvoy S; Johnson WB; Cheung TH; Chung TK; Lo KW; Yim SF; Yu MM; Ngan HY; Wong YF; Smith DI
Oncogene; 2005 Jun; 24(24):3875-85. PubMed ID: 15735666
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
Suo ST; Gong P; Peng XJ; Niu D; Guo YT
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
[TBL] [Abstract][Full Text] [Related]
4. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
Fu J; Cai H; Wu Y; Fang S; Wang D
Gene; 2020 Sep; 755():144886. PubMed ID: 32534055
[TBL] [Abstract][Full Text] [Related]
5. KLF2 Inhibits the Migration and Invasion of Prostate Cancer Cells by Downregulating MMP2.
Wang B; Liu M; Song Y; Li C; Zhang S; Ma L
Am J Mens Health; 2019; 13(1):1557988318816907. PubMed ID: 30520325
[TBL] [Abstract][Full Text] [Related]
6. miR-92a-3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis.
Yu ZH; Chen ZH; Zhou GL; Zhou XJ; Ma HY; Yu Y; Wang X; Cao XC
Thorac Cancer; 2022 Nov; 13(21):2992-3000. PubMed ID: 36100919
[TBL] [Abstract][Full Text] [Related]
7. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6605-11. PubMed ID: 24377575
[TBL] [Abstract][Full Text] [Related]
8. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
[TBL] [Abstract][Full Text] [Related]
9. The Urtica dioica extract enhances sensitivity of paclitaxel drug to MDA-MB-468 breast cancer cells.
Mohammadi A; Mansoori B; Aghapour M; Shirjang S; Nami S; Baradaran B
Biomed Pharmacother; 2016 Oct; 83():835-842. PubMed ID: 27501501
[TBL] [Abstract][Full Text] [Related]
10. [miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human nasopharyngeal carcinoma cells by targeting inhibition of WEE1 kinase].
Zhang H; Lu J; Jiang C; Lu W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1014-1019. PubMed ID: 31878998
[TBL] [Abstract][Full Text] [Related]
11. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
13. Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma.
Wu N; Chen S; Luo Q; Jiang Z; Wang X; Li Y; Qiu J; Yu K; Yang Y; Zhuang J
Exp Eye Res; 2022 Mar; 216():108955. PubMed ID: 35074341
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis.
Wang L; Su K; Wu H; Li J; Song D
Life Sci; 2019 Sep; 232():116597. PubMed ID: 31238052
[TBL] [Abstract][Full Text] [Related]
15. miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.
You F; Luan H; Sun D; Cui T; Ding P; Tang H; Sun D
DNA Cell Biol; 2019 Feb; 38(2):198-207. PubMed ID: 30570350
[TBL] [Abstract][Full Text] [Related]
16. HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer.
Dou Z; Qiu C; Zhang X; Yao S; Zhao C; Wang Z; Chu R; Chen J; Chen Z; Li R; Wang K; Liu P; Liu C; Song K; Kong B
Int J Biol Sci; 2022; 18(3):1188-1210. PubMed ID: 35173547
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
18. Silencing of lncRNA PART1 inhibits proliferation, invasion and migration of breast cancer cells and promotes the efficacy of cisplatin in breast cancer cells.
Zhang L; Zhang J; Ni C
Gen Physiol Biophys; 2020 Jul; 39(4):343-354. PubMed ID: 32700682
[TBL] [Abstract][Full Text] [Related]
19. WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance.
Zheng H; Shao F; Martin S; Xu X; Deng CX
Sci Rep; 2017 Mar; 7():43517. PubMed ID: 28262781
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
